Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iNUDGE: INtegration of liqUiD Biopsy Based Next Generation Gene sEquencing in Newly Diagnosed NSCLC - A Stepped Wedge Cluster Randomized Clinical Trial

NCT05853887 is registered in ClinicalTrials.gov with Charu Aggarwal as lead sponsor.

NCT NCT05853887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05853887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iNUDGE: INtegration of liqUiD Biopsy Based Next Generation Gene sEquencing in Newly Diagnosed NSCLC - A Stepped Wedge Cluster Randomized Clinical Trial
Lead sponsor
Charu Aggarwal
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 15, 2023
Completion date
December 31, 2026
Enrollment
260 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed nsclc, non small cell lung cancer metastatic, non-squamous non-small cell neoplasm of lung